Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Neoplasms × High-Intensity Interval Training × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pediatric Brain Tumor 1 Motor Activity 1 Lung Neoplasms 1 Hodgkin Disease 1 Esophageal Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 45 Specimen Handling 42 Carboplatin 40 Magnetic Resonance Spectroscopy 34 Pemetrexed 33 Cisplatin 29 durvalumab 23 atezolizumab 20 Paclitaxel 18 Radiosurgery 17 Nivolumab 16 Immunoglobulin G 15 osimertinib 14 Gemcitabine 14 Disulfides 14 Radiotherapy 13 Biopsy 11 130-nm albumin-bound paclitaxel 11 Platinum 9 Cetuximab 9 X-Rays 8 Radiation 8 Docetaxel 8 1,2-diaminocyclohexaneplatinum II citrate 8 Standard of Care 7 Etoposide 7 Bevacizumab 7 cemiplimab 6 Taxes 6 Practice Guidelines as Topic 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06026111 2026-01-21

ENHANCE

Dana-Farber Cancer Institute

Phase NA Recruiting

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡